A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction
Public ClinicalTrials.gov record NCT06082037. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Study, Followed by Open-label Extensions, to Evaluate the Efficacy of Oral Belumosudil in Adult Participants With Chronic Lung Allograft Dysfunction (CLAD) Following Bilateral Lung Transplantation
Study identification
- NCT ID
- NCT06082037
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Sanofi
- Industry
- Enrollment
- 180 participants
Conditions and interventions
Conditions
Interventions
- Azithromycin Drug
- Belumosudil Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 9, 2023
- Primary completion
- Jan 28, 2029
- Completion
- Sep 30, 2030
- Last update posted
- Apr 12, 2026
2023 – 2030
United States locations
- U.S. sites
- 31
- U.S. states
- 16
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham- Site Number : 8400026 | Birmingham | Alabama | 35233 | Recruiting |
| St. Joseph's Hospital and Medical Center- Site Number : 8400019 | Phoenix | Arizona | 85013 | Recruiting |
| University of California Los Angeles Medical Center- Site Number : 8400020 | Los Angeles | California | 90095 | Recruiting |
| Stanford University Medical Center- Site Number : 8400008 | Stanford | California | 94305 | Recruiting |
| Mayo Clinic in Florida- Site Number : 8400031 | Jacksonville | Florida | 32224 | Recruiting |
| Jackson Memorial Hospital- Site Number : 8400030 | Miami | Florida | 33136 | Recruiting |
| AdventHealth Orlando- Site Number : 8400023 | Orlando | Florida | 32803 | Recruiting |
| Tampa General Hospital - Tampa - General Circle- Site Number : 8400015 | Tampa | Florida | 33606 | Recruiting |
| Emory University Hospital- Site Number : 8400027 | Atlanta | Georgia | 30324 | Recruiting |
| Northwestern University- Site Number : 8400003 | Chicago | Illinois | 60611 | Recruiting |
| Loyola University Medical Center- Site Number : 8400025 | Maywood | Illinois | 60153 | Recruiting |
| University of Iowa- Site Number : 8400032 | Iowa City | Iowa | 52242 | Recruiting |
| University of Maryland School of Medicine - Baltimore- Site Number : 8400009 | Baltimore | Maryland | 21201 | Recruiting |
| Johns Hopkins Hospital- Site Number : 8400034 | Baltimore | Maryland | 21287 | Recruiting |
| University of Michigan Health System - Ann Arbor- Site Number : 8400014 | Ann Arbor | Michigan | 48109 | Recruiting |
| Corewell Health - Grand Rapids - Michigan Street Northeast- Site Number : 8400010 | Grand Rapids | Michigan | 49503 | Recruiting |
| NYU Perlmutter Cancer Center - Energy Building- Site Number : 8400001 | New York | New York | 10016 | Recruiting |
| Icahn School of Medicine at Mount Sinai- Site Number : 8400037 | New York | New York | 10029 | Recruiting |
| Columbia University Irving Medical Center- Site Number : 8400002 | New York | New York | 10032 | Recruiting |
| Montefiore Medical Center - Moses Campus- Site Number : 8400036 | The Bronx | New York | 10467 | Recruiting |
| Duke University Medical Center- Site Number : 8400017 | Durham | North Carolina | 27710 | Recruiting |
| Cleveland Clinic - Cleveland- Site Number : 8400005 | Cleveland | Ohio | 44195 | Recruiting |
| The Ohio State University- Site Number : 8400028 | Columbus | Ohio | 43210 | Recruiting |
| Penn Medicine: University of Pennsylvania Health System- Site Number : 8400006 | Philadelphia | Pennsylvania | 19104 | Recruiting |
| Temple University Hospital- Site Number : 8400007 | Philadelphia | Pennsylvania | 19140 | Recruiting |
| Vanderbilt University Medical Center- Site Number : 8400018 | Nashville | Tennessee | 37232 | Recruiting |
| University of Texas - Southwestern Medical Center- Site Number : 8400013 | Dallas | Texas | 75390 | Recruiting |
| Baylor College of Medicine- Site Number : 8400024 | Houston | Texas | 77030 | Recruiting |
| Houston Methodist Hospital- Site Number : 8400021 | Houston | Texas | 77030 | Recruiting |
| University Health System - San Antonio- Site Number : 8400035 | San Antonio | Texas | 78229 | Recruiting |
| Inova Fairfax Hospital- Site Number : 8400004 | Falls Church | Virginia | 22042 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06082037, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 12, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06082037 live on ClinicalTrials.gov.